Marianne De Backer, Vir Biotechnology CEO

'Have to keep up this pace': As new Vir CEO, Mar­i­anne De Backer eyes ex­pan­sion be­yond in­fec­tious dis­ease

On day two in the CEO seat at Vir Biotech­nol­o­gy, Mar­i­anne De Backer — a pro­lif­ic, two-decade deal­mak­er in bio­phar­ma — said she’s ready to move fast …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.